Single morning and nightly doses of ranitidine 300 mg: An appraisal of their antisecretory effects by continuous ph monitoring1

Vincenzo Savarino, Giuseppe Sandro Mela, Patrizia Zentilin, Alessandro Sumberaz, Patrizia Cutela, Guido Celle

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Gastric acidity of 12 patients with healed duodenal ulcers was continuously monitored over 24 h in order to assess the antisecretory effects of two different administration times of a single daily dose of ranitidine 300 mg. Each patient orally received either (a) placebo at 08.00 h and 22.00 h; (b) ranitidine 300 mg at 08.00 h and placebo at 22.00 h, or (c) placebo at 08.00 h and ranitidine 300 mg at 22.00 h in randomized and double-blind fashion. Each medication was administered on three separate occasions, with intervals of at least 1 week. Both the morning and the bedtime doses of ranitidine were significantly superior (p <0.001) to placebo in controlling 24-hour gastric acidity, while, in the same period, ranitidine nocte was more effective (p <0.001) than ranitidine mane. During the night, bedtime ranitidine caused more acid inhibition (p <0.001) than morning ranitidine, but the opposite (p <0.01) occurred during the daytime. This study shows that the antisecretory effect of morning ranitidine during the daytime is less consistent than that achieved by bedtime ranitidine during the nocturnal period. As similar rates of duodenal ulcer healing have recently been achieved with morning and conventional nighttime administration of Ho antagonists, it becomes clear that antisecretory drugs can also be beneficial with an acid inhibition which is shorter-lasting than that which was previously thought to be necessary or, alternatively, that also daytime acidity is important in ulcerogenesis.

Original languageEnglish
Pages (from-to)141-148
Number of pages8
JournalDigestion
Volume48
Issue number3
DOIs
Publication statusPublished - 1991

Fingerprint

Ranitidine
Placebos
Duodenal Ulcer
Stomach
Acids

Keywords

  • Bedtime dose
  • H<inf>2</inf> antagonists
  • Morning dose
  • PH monitoring

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Single morning and nightly doses of ranitidine 300 mg : An appraisal of their antisecretory effects by continuous ph monitoring1. / Savarino, Vincenzo; Mela, Giuseppe Sandro; Zentilin, Patrizia; Sumberaz, Alessandro; Cutela, Patrizia; Celle, Guido.

In: Digestion, Vol. 48, No. 3, 1991, p. 141-148.

Research output: Contribution to journalArticle

Savarino, Vincenzo ; Mela, Giuseppe Sandro ; Zentilin, Patrizia ; Sumberaz, Alessandro ; Cutela, Patrizia ; Celle, Guido. / Single morning and nightly doses of ranitidine 300 mg : An appraisal of their antisecretory effects by continuous ph monitoring1. In: Digestion. 1991 ; Vol. 48, No. 3. pp. 141-148.
@article{7c62604420ec479e96b45e11a38922fa,
title = "Single morning and nightly doses of ranitidine 300 mg: An appraisal of their antisecretory effects by continuous ph monitoring1",
abstract = "Gastric acidity of 12 patients with healed duodenal ulcers was continuously monitored over 24 h in order to assess the antisecretory effects of two different administration times of a single daily dose of ranitidine 300 mg. Each patient orally received either (a) placebo at 08.00 h and 22.00 h; (b) ranitidine 300 mg at 08.00 h and placebo at 22.00 h, or (c) placebo at 08.00 h and ranitidine 300 mg at 22.00 h in randomized and double-blind fashion. Each medication was administered on three separate occasions, with intervals of at least 1 week. Both the morning and the bedtime doses of ranitidine were significantly superior (p <0.001) to placebo in controlling 24-hour gastric acidity, while, in the same period, ranitidine nocte was more effective (p <0.001) than ranitidine mane. During the night, bedtime ranitidine caused more acid inhibition (p <0.001) than morning ranitidine, but the opposite (p <0.01) occurred during the daytime. This study shows that the antisecretory effect of morning ranitidine during the daytime is less consistent than that achieved by bedtime ranitidine during the nocturnal period. As similar rates of duodenal ulcer healing have recently been achieved with morning and conventional nighttime administration of Ho antagonists, it becomes clear that antisecretory drugs can also be beneficial with an acid inhibition which is shorter-lasting than that which was previously thought to be necessary or, alternatively, that also daytime acidity is important in ulcerogenesis.",
keywords = "Bedtime dose, H<inf>2</inf> antagonists, Morning dose, PH monitoring",
author = "Vincenzo Savarino and Mela, {Giuseppe Sandro} and Patrizia Zentilin and Alessandro Sumberaz and Patrizia Cutela and Guido Celle",
year = "1991",
doi = "10.1159/000200686",
language = "English",
volume = "48",
pages = "141--148",
journal = "Digestion",
issn = "0012-2823",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Single morning and nightly doses of ranitidine 300 mg

T2 - An appraisal of their antisecretory effects by continuous ph monitoring1

AU - Savarino, Vincenzo

AU - Mela, Giuseppe Sandro

AU - Zentilin, Patrizia

AU - Sumberaz, Alessandro

AU - Cutela, Patrizia

AU - Celle, Guido

PY - 1991

Y1 - 1991

N2 - Gastric acidity of 12 patients with healed duodenal ulcers was continuously monitored over 24 h in order to assess the antisecretory effects of two different administration times of a single daily dose of ranitidine 300 mg. Each patient orally received either (a) placebo at 08.00 h and 22.00 h; (b) ranitidine 300 mg at 08.00 h and placebo at 22.00 h, or (c) placebo at 08.00 h and ranitidine 300 mg at 22.00 h in randomized and double-blind fashion. Each medication was administered on three separate occasions, with intervals of at least 1 week. Both the morning and the bedtime doses of ranitidine were significantly superior (p <0.001) to placebo in controlling 24-hour gastric acidity, while, in the same period, ranitidine nocte was more effective (p <0.001) than ranitidine mane. During the night, bedtime ranitidine caused more acid inhibition (p <0.001) than morning ranitidine, but the opposite (p <0.01) occurred during the daytime. This study shows that the antisecretory effect of morning ranitidine during the daytime is less consistent than that achieved by bedtime ranitidine during the nocturnal period. As similar rates of duodenal ulcer healing have recently been achieved with morning and conventional nighttime administration of Ho antagonists, it becomes clear that antisecretory drugs can also be beneficial with an acid inhibition which is shorter-lasting than that which was previously thought to be necessary or, alternatively, that also daytime acidity is important in ulcerogenesis.

AB - Gastric acidity of 12 patients with healed duodenal ulcers was continuously monitored over 24 h in order to assess the antisecretory effects of two different administration times of a single daily dose of ranitidine 300 mg. Each patient orally received either (a) placebo at 08.00 h and 22.00 h; (b) ranitidine 300 mg at 08.00 h and placebo at 22.00 h, or (c) placebo at 08.00 h and ranitidine 300 mg at 22.00 h in randomized and double-blind fashion. Each medication was administered on three separate occasions, with intervals of at least 1 week. Both the morning and the bedtime doses of ranitidine were significantly superior (p <0.001) to placebo in controlling 24-hour gastric acidity, while, in the same period, ranitidine nocte was more effective (p <0.001) than ranitidine mane. During the night, bedtime ranitidine caused more acid inhibition (p <0.001) than morning ranitidine, but the opposite (p <0.01) occurred during the daytime. This study shows that the antisecretory effect of morning ranitidine during the daytime is less consistent than that achieved by bedtime ranitidine during the nocturnal period. As similar rates of duodenal ulcer healing have recently been achieved with morning and conventional nighttime administration of Ho antagonists, it becomes clear that antisecretory drugs can also be beneficial with an acid inhibition which is shorter-lasting than that which was previously thought to be necessary or, alternatively, that also daytime acidity is important in ulcerogenesis.

KW - Bedtime dose

KW - H<inf>2</inf> antagonists

KW - Morning dose

KW - PH monitoring

UR - http://www.scopus.com/inward/record.url?scp=0025873584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025873584&partnerID=8YFLogxK

U2 - 10.1159/000200686

DO - 10.1159/000200686

M3 - Article

C2 - 1916034

AN - SCOPUS:0025873584

VL - 48

SP - 141

EP - 148

JO - Digestion

JF - Digestion

SN - 0012-2823

IS - 3

ER -